离婚后，婆婆要我房门的钥匙，我该给吗？# Love - 情爱幽幽
b*d
1 楼
【 以下文字转载自 Biology 讨论区 】
发信人: zhiduoduo (Transform), 信区: Biology
标 题: Senate panel approves $2 billion raise for NIH in 2016
发信站: BBS 未名空间站 (Fri Jun 26 11:10:17 2015, 美东)
这点钱还不够美军造艘船的成本，虽然不多，也比没有好点。
By Jocelyn Kaiser 23 June 2015 5:15 pm 2 Comments
At last, biomedical researchers may be getting some relief. A Senate panel
today approved a bill that would bestow a generous $2 billion increase on
the National Institutes of Health (NIH) in 2016, or what appears to be a 6%
raise, to $32 billion. Although a House of Representatives panel last week
approved a lower figure, it seems the agency may be on track to its first
significant increase in more than a decade.
The draft bill approved today by the Senate appropriations panel that
oversees NIH’s budget would give the agency twice the $1 billion proposed
by the Obama administration and $900 million more than the corresponding
House panel, according to a summary statement.
The National Institute on Aging, which the panel notes funds Alzheimer’s
disease research, would receive $350 million more, or a roughly 25% increase
. (The House version of the bill also favors Alzheimer’s, but takes a
different approach, directly earmarking $300 million for the disease—$250
million more than the president’s request.)
The Senate measure matches the president’s request of $200 million for a
Precision Medicine Initiative, and $100 million in new funding for NIH’s
part of a transagency antibiotics initiative. The BRAIN brain-mapping
initiative would receive $135 million, nearly twice the $70 million
requested by the president. The Institutional Development Awards for states
with relatively little NIH funding, which the president’s budget flat
funded at $273 million, would receive a $27 million increase.
Since Congress completed a 5-year doubling of the NIH budget in 2003, the
agency’s funding level has fallen more than 20% below the 2003 level after
taking into account the rising costs of biomedical research. That has led to
fierce competition and record-low success rates for researchers applying
for NIH grants.
The bill goes to the full Senate Appropriations Committee on Thursday. It
would normally head to the Senate floor next, but that may not happen any
time soon because of a political dispute between Republicans and Democrats
over long-term budgeting issues. Eventually, the House and Senate will need
to reconcile the numbers in the two bills; usually they meet somewhere in
the middle. Any final NIH spending number for the 2016 fiscal year that
begins 1 October may not be clear until late this year.
“The Senate mark is obviously the best subcommittee action we have seen for
NIH in more than 12 years. It shows that there is real momentum on a
bipartisan basis in the House and the Senate that the restoration of NIH
funding is priority,” says Pat White, president of ACT for NIH, a group in
Washington, D.C., that lobbies for biomedical research funding.
A measure called the 21st Century Cures Act that is awaiting a vote by the
full House would give NIH an additional $2 billion a year through 2020 from
funds that are separate from the usual appropriations process.
Posted in Funding, Policy Budget 2016
http://news.sciencemag.org/funding/2015/06/senate-panel-approve
发信人: zhiduoduo (Transform), 信区: Biology
标 题: Senate panel approves $2 billion raise for NIH in 2016
发信站: BBS 未名空间站 (Fri Jun 26 11:10:17 2015, 美东)
这点钱还不够美军造艘船的成本，虽然不多，也比没有好点。
By Jocelyn Kaiser 23 June 2015 5:15 pm 2 Comments
At last, biomedical researchers may be getting some relief. A Senate panel
today approved a bill that would bestow a generous $2 billion increase on
the National Institutes of Health (NIH) in 2016, or what appears to be a 6%
raise, to $32 billion. Although a House of Representatives panel last week
approved a lower figure, it seems the agency may be on track to its first
significant increase in more than a decade.
The draft bill approved today by the Senate appropriations panel that
oversees NIH’s budget would give the agency twice the $1 billion proposed
by the Obama administration and $900 million more than the corresponding
House panel, according to a summary statement.
The National Institute on Aging, which the panel notes funds Alzheimer’s
disease research, would receive $350 million more, or a roughly 25% increase
. (The House version of the bill also favors Alzheimer’s, but takes a
different approach, directly earmarking $300 million for the disease—$250
million more than the president’s request.)
The Senate measure matches the president’s request of $200 million for a
Precision Medicine Initiative, and $100 million in new funding for NIH’s
part of a transagency antibiotics initiative. The BRAIN brain-mapping
initiative would receive $135 million, nearly twice the $70 million
requested by the president. The Institutional Development Awards for states
with relatively little NIH funding, which the president’s budget flat
funded at $273 million, would receive a $27 million increase.
Since Congress completed a 5-year doubling of the NIH budget in 2003, the
agency’s funding level has fallen more than 20% below the 2003 level after
taking into account the rising costs of biomedical research. That has led to
fierce competition and record-low success rates for researchers applying
for NIH grants.
The bill goes to the full Senate Appropriations Committee on Thursday. It
would normally head to the Senate floor next, but that may not happen any
time soon because of a political dispute between Republicans and Democrats
over long-term budgeting issues. Eventually, the House and Senate will need
to reconcile the numbers in the two bills; usually they meet somewhere in
the middle. Any final NIH spending number for the 2016 fiscal year that
begins 1 October may not be clear until late this year.
“The Senate mark is obviously the best subcommittee action we have seen for
NIH in more than 12 years. It shows that there is real momentum on a
bipartisan basis in the House and the Senate that the restoration of NIH
funding is priority,” says Pat White, president of ACT for NIH, a group in
Washington, D.C., that lobbies for biomedical research funding.
A measure called the 21st Century Cures Act that is awaiting a vote by the
full House would give NIH an additional $2 billion a year through 2020 from
funds that are separate from the usual appropriations process.
Posted in Funding, Policy Budget 2016
http://news.sciencemag.org/funding/2015/06/senate-panel-approve
